A case of microscopic polyangiitis following mycoplasma infection in a patient with MPO-ANCA positive pulmonary fibrosis

Allergol Int. 2011 Mar;60(1):93-6. doi: 10.2332/allergolint.10-CR-0216. Epub 2010 Nov 24.

Abstract

Background: Microscopic polyangiitis is a vasculitic disease that may result in a pulmonary renal syndrome. Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is strongly associated with infection.

Case summary: We describe a case of microscopic polyangiitis that developed in a patient with MPO-ANCA positive pulmonary fibrosis following infection with mycoplasma. A renal biopsy was undertaken following the detection of microscopic hematuria during follow-up but no abnormal findings were evident. The MPO-ANCA titer increased following infection with mycoplasma pneumonia and a second renal biopsy demonstrated crescentic glomerulonephritis. The degree of pulmonary fibrosis was unaffected.

Discussion: The present case suggests that the mycoplasma infection triggered the elevation of MPO-ANCA titer and provoked glomerulonephritis in a patient with MPO-ANCA positive IPF. This case indicates the importance of testing for MPO-ANCA at the time of initial diagnosis, performing urinalysis and examining the urine sediment during follow-up and being alert to the potential onset of vasculitis in cases of pulmonary fibrosis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Female
  • Glomerulonephritis / complications
  • Glomerulonephritis / diagnosis
  • Glomerulonephritis / drug therapy
  • Glomerulonephritis / immunology
  • Glomerulonephritis / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Microscopic Polyangiitis / diagnosis
  • Microscopic Polyangiitis / drug therapy
  • Microscopic Polyangiitis / etiology*
  • Microscopic Polyangiitis / immunology
  • Middle Aged
  • Mycoplasma Infections / complications*
  • Mycoplasma Infections / diagnosis
  • Mycoplasma Infections / drug therapy
  • Mycoplasma Infections / immunology
  • Pulmonary Fibrosis / complications*
  • Pulmonary Fibrosis / diagnosis
  • Pulmonary Fibrosis / diagnostic imaging
  • Pulmonary Fibrosis / drug therapy
  • Pulmonary Fibrosis / immunology
  • Radiography
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Antibodies, Antineutrophil Cytoplasmic
  • Immunosuppressive Agents